Search results for "LUMA"

showing 10 items of 227 documents

Seasonal changes in some thermoregulatory variables of the house sparrow (Passer domesticus L.)

1975

Abstract 1. The body weight, plumage, insulation, oxygen consumption and body lipids were studied seasonally in the house sparrow, Passer domesticus L. 2. The weights of body and plumage were greater in autumn and winter than in summer. 3. The insulative property of the plumage was better in autumn and winter birds than in summer birds. 4. The oxygen consumption of young birds was higher than that of plucked and adult birds. 5. The amount of subcutaneous depot fat tissue and its lipid content was greatest in autumn. The C18-unsaturated fatty acids were most prominent in the subcutaneous fat. Palmitic acid was the most prevalent fatty acid in the liver. The relative amount of C18-unsaturated…

AgingAdipose tissueBiologyBody TemperatureBirdsPalmitic acidchemistry.chemical_compoundOxygen ConsumptionAnimal sciencebiology.animalAnimalschemistry.chemical_classificationSparrowEcologyFatty AcidsFatty acidGeneral MedicineFeathersThermoregulationbiology.organism_classificationAdaptation PhysiologicalAdipose TissueLiverchemistryPlumageFeathervisual_artvisual_art.visual_art_mediumSeasonsPasserBody Temperature RegulationComparative Biochemistry and Physiology Part A: Physiology
researchProduct

Immuno-oncological treatment of Non-Small-Cell Lung Cancer (NSCLC) in advanced stage with Nivolumab

2023

Immuno-oncology marked a therapeutic revolution in the treatment of cancer. Thanks to the new strategy that aims to awaken the immune system to fight cancer cells, there has been a change in the clinical course in the treatment of advanced Non-Small Cell Lung Cancer (NSCLC). Our study aimed to evaluate the therapeutic efficacy of nivolumab monotherapy in the treatment of patients with advanced stage IIIB/IV non-small cell lung cancer beyond the second line. The results showed a progression-free survival of 7.35 months and an improvement in the quality of life of patients compared to other treatments. In addition, no type 3 and type 4 adverse reactions were detected in patients treated with …

Biochemistry (medical)Settore BIO/14 - FarmacologiacancerPlant ScienceSettore MED/49 - Scienze Tecniche Dietetiche Applicateimmuno-oncologyNivolumab.Settore CHIM/08 - Chimica FarmaceuticaGeneral Biochemistry Genetics and Molecular Biologylung
researchProduct

ECOLOGIA DELL' IMPOLLINAZIONE DI PERIPLOCA LAEVIGATA SUBSP ANGUSTIFOLIA ( LABILL.) MARKGRAF ( APOCYNACEAE-PERIPLOCOIDEAE ) E CALLUMA EUROPEA N.E.BR. …

2011

CALLUMALAMPEDUSAECOLOGIA DELL' IMPOLLINAZIONE DI PERIPLOCA LAEVIGATA SUBSP ANGUSTIFOLIAMARKGRAFSettore BIO/03 - Botanica Ambientale E Applicata
researchProduct

Sexing adult Cory's Shearwater by discriminant analysis of body measurements on Linosa Island (Sicilian Channel), Italy

2001

-Males and females of many avian species may show no plumage dimorphism, but often can be sexed by differences in body measurements. Sex determination of many Cory's Shearwaters Calonectris diomedea, was possible by multiplying bill length by bill depth. In this study, discriminant analysis of six measurements (bill length, bill depth, wing, tail, tarsus and mass) was performed on Cory's Shearwaters breeding on Linosa Island (Sicilian Channel), Italy and the efficiency of sex determination was compared with the univariate method. Results show the advantages of the discriminant functions. Bill depth is the best parameter (up to 92% correct classification), followed by mass (84% correct class…

Calonectris diomedeaDiscriminant analysiZoologySexingBiologyLinear discriminant analysisbiology.organism_classificationlanguage.human_languageSexual dimorphismPlumageCory's ShearwaterlanguageCalonectris diomedeaAnimal Science and ZoologyCory's shearwaterSicilianSicily
researchProduct

Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review an…

2021

Background: Frontline immune checkpoint inhibitors (ICI)-based regimens in non-oncogene-addicted non-small-cell lung cancer (NSCLC) have been deeply investigated. To rank the available therapeutic options, we carried out a systematic review and Bayesian meta-analysis. Methods: A comprehensive search for randomized controlled trials (RCTs) of ICI regimens, and a pairwise and a network meta-analysis (NMA) with an all-comers and a stratified strategy were conducted. Endpoints were overall survival (OS), progression-free survival (PFS), objective response rate (ORR) and treatment-related adverse events (TRAEs). Results: Nineteen RCTs involving 17 treatment regimens were included. For the all-co…

Cancer ResearchLung Neoplasmscheckpoints inhibitorsIpilimumabB7-H1 AntigenBevacizumabAntineoplastic Agents ImmunologicalNivolumabnon-small-cell lung cancersystematic reviewOncologyCarcinoma Non-Small-Cell LungHumansnetwork meta-analysisfrontline therapyESMO Open
researchProduct

Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma

2022

Background: Statins are widely used in an ageing population, including subjects with solid malignancies. However, no conclusive evidence is currently available on their potential influence on patients' outcome. We aimed to assess whether statin exposure affects the survival of patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab.Patients and methods: Medical records of patients with documented mRCC treated with second- or third-line nivolumab were reviewed at ten institutions from Italy, Spain and the USA. Patients were assessed for overall survival (OS), progression-free survival (PFS), and overall clinical benefit. Univariate and multivariate analyses were used to e…

Cancer ResearchSurvivalTumour responseStatinRenal cell carcinomaProgression-Free SurvivalKidney NeoplasmsNivolumabTreatment OutcomeOncologyChild PreschoolHumansImmunotherapyHydroxymethylglutaryl-CoA Reductase InhibitorsConcomitant medicationsCarcinoma Renal CellRetrospective Studies
researchProduct

Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2-a…

2020

278 Background: We report the primary analysis of JAVELIN Gastric 100, which compared avelumab (anti–PD-L1) maintenance after 1L CTx vs continued CTx in patients (pts) with GC/GEJC. Methods: In this global, open-label, phase 3 trial (NCT02625610), eligible pts had previously untreated, unresectable, locally advanced/metastatic (LA/M) HER2− GC/GEJC. Pts without progressive disease (PD) after 12 weeks of 1L oxaliplatin/fluoropyrimidine induction were randomized 1:1 to avelumab 10 mg/kg Q2W switch maintenance or continued CTx, stratified by region (Asia vs non-Asia). Primary endpoint was overall survival (OS) post induction in all randomized or PD-L1+ (≥1% of tumor cells, 73-10 assay) pts. Re…

Cancer Researchmedicine.medical_specialtyChemotherapybiologybusiness.industryFirst linemedicine.medical_treatmentCancerbiology.organism_classificationmedicine.diseaseGastroesophageal JunctionGastroenterologyAvelumabOncologyJavelinInternal medicinemedicineIn patientbusinessmedicine.drug
researchProduct

Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab

2023

BackgroundMerkel cell carcinoma (MCC) is a rare and aggressive skin cancer, associated with a worse prognosis. The Immune Checkpoint Inhibitors (ICIs) avelumab and pembrolizumab have been recently approved as first-line treatment in metastatic MCC (mMCC). The clinical observation of improved outcomes in obese patients following treatment with ICIs, known as the “obesity paradox”, has been studied across many types of tumors. Probably due to the rarity of this tumor, data on mMMC patients are lacking.Patients and methodsThis is an observational, hospital-based, study to investigate the role of Body Mass Index (BMI) as predictive biomarker of ICI response in mMCC patients treated with aveluma…

Cancer Researchpredictive factorsOncologyskin cancer non melanomaavelumabimmunotherapybody mass index - BMIMerkel cell carcinoma (MCC)Frontiers in Oncology
researchProduct

Genome-Wide Analyses Identifies Known and New Markers Responsible of Chicken Plumage Color

2020

Simple Summary In order to assess sources of variation related to Polverara breed plumage color (black vs. white), we carried out genome-wide analyses to identify the genomic regions involved in this trait. The present work has revealed new candidate genes involved in the phenotypic variability in local chicken populations. These results also contribute insights into the genetic basis for plumage color in poultry, and confirm the great complexity of the mechanisms that control this trait. Abstract Through the development of the high-throughput genotyping arrays, molecular markers and genes related to phenotypic traits have been identified in livestock species. In poultry, plumage color is a…

Candidate geneCandidate genegenome-wide analysesCandidate genes; Genome-wide analyses; Local chicken populations; Plumage color; SNPSNPSingle-nucleotide polymorphismGenome-wide association studyBiologyArticleFixation indexSettore AGR/17 - Zootecnica Generale E Miglioramento Genetico03 medical and health scienceslcsh:ZoologyGenetic variationlcsh:QL1-991GenotypingLocal chicken population030304 developmental biologyGeneticsGenome-wide analyse0303 health scienceslcsh:Veterinary medicineGeneral Veterinarylocal chicken populations0402 animal and dairy science04 agricultural and veterinary sciencesPhenotypic traitlocal chicken populations; genome-wide analyses; SNP; plumage color; candidate genes040201 dairy & animal sciencePlumage colorPlumagelcsh:SF600-1100Animal Science and Zoologycandidate genesAnimals
researchProduct

Ecologia dell'impollinazione di Periploca laevigata subsp. angustifolia (Labill.) Markgraf (Apocynaceae-Periplocoideae) e Caralluma europaea N.E.Br. …

2011

Caralluma europaeaSettore BIO/03 - Botanica Ambientale E Applicataisola di Lampedusa.Periploca laevigata subsp. angustifolia
researchProduct